|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
357,741,000 |
Market
Cap: |
133.31(B) |
Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
52
Week Range: |
$258.49 - $400.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ-100 |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1071 |
Guru Rank Value : -4.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
255,869 |
290,136 |
408,483 |
778,755 |
Total Sell Value |
$98,735,492 |
$109,899,457 |
$146,089,202 |
$238,758,936 |
Total People Sold |
8 |
9 |
12 |
12 |
Total Sell Transactions |
23 |
30 |
43 |
68 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brosius Mark |
SVP & Chief Mfg and Supply Cha |
|
2024-03-05 |
4 |
AS |
$400.00 |
$78,400 |
D/D |
(196) |
1,842 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2024-03-01 |
4 |
AS |
$383.48 |
$615,485 |
D/D |
(1,605) |
298 |
|
- |
|
Guthart Gary S |
CEO |
|
2024-02-29 |
4 |
D |
$386.59 |
$1,248,686 |
D/D |
(3,230) |
15,358 |
|
- |
|
Guthart Gary S |
CEO |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,370 |
16,629 |
|
- |
|
Widman Fredrik |
VP Corporate Controller |
|
2024-02-29 |
4 |
D |
$386.59 |
$181,697 |
D/D |
(470) |
3,927 |
|
- |
|
Widman Fredrik |
VP Corporate Controller |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,317 |
4,094 |
|
- |
|
Samath Jamie |
Chief Financial Officer |
|
2024-02-29 |
4 |
D |
$386.59 |
$381,564 |
D/D |
(987) |
8,757 |
|
- |
|
Samath Jamie |
Chief Financial Officer |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,006 |
9,139 |
|
- |
|
Miller Brian Edward |
EVP & Chief Digital Officer |
|
2024-02-29 |
4 |
D |
$386.59 |
$552,051 |
D/D |
(1,428) |
12,172 |
|
- |
|
Miller Brian Edward |
EVP & Chief Digital Officer |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,817 |
13,028 |
|
- |
|
Mohr Marshall |
Executive VP Global Business S |
|
2024-02-29 |
4 |
D |
$386.59 |
$638,260 |
D/D |
(1,651) |
49,502 |
|
- |
|
Mohr Marshall |
Executive VP Global Business S |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,256 |
50,011 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2024-02-29 |
4 |
D |
$386.59 |
$638,260 |
D/D |
(1,651) |
1,903 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,256 |
3,045 |
|
- |
|
Brosius Mark |
SVP & Chief Mfg and Supply Cha |
|
2024-02-29 |
4 |
D |
$386.59 |
$361,462 |
D/D |
(935) |
2,038 |
|
- |
|
Brosius Mark |
SVP & Chief Mfg and Supply Cha |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,843 |
2,483 |
|
- |
|
Rosa David J. |
President |
|
2024-02-29 |
4 |
D |
$386.59 |
$736,454 |
D/D |
(1,905) |
217,792 |
|
- |
|
Rosa David J. |
President |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,757 |
218,555 |
|
- |
|
Charlton Henry L |
SVP & Chief Commercial and Mkt |
|
2024-02-29 |
4 |
D |
$386.59 |
$378,858 |
D/D |
(980) |
23,486 |
|
- |
|
Charlton Henry L |
SVP & Chief Commercial and Mkt |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,201 |
23,824 |
|
- |
|
Desantis Robert |
EVP & Chief Strategy & Corp Op |
|
2024-02-29 |
4 |
D |
$386.59 |
$657,203 |
D/D |
(1,700) |
11,075 |
|
- |
|
Desantis Robert |
EVP & Chief Strategy & Corp Op |
|
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,676 |
11,772 |
|
- |
|
Mohr Marshall |
Executive VP Global Business S |
|
2024-02-28 |
4 |
AS |
$385.08 |
$41,893,066 |
D/D |
(108,790) |
47,897 |
|
- |
|
Mohr Marshall |
Executive VP Global Business S |
|
2024-02-28 |
4 |
OE |
$77.00 |
$18,478,437 |
D/D |
129,810 |
58,397 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2024-02-27 |
4 |
AS |
$386.46 |
$325,786 |
D/D |
(843) |
298 |
|
- |
|
2128 Records found
|
|
Page 2 of 86 |
|
|